This video reviews the advantages and disadvantages of IMRT and proton therapy for the treatment of esophageal cancer.
The current standard for treating patients with esophageal cancer is 3D radiation, but newer technologies such as intensity-modulated radiation therapy (IMRT) and proton therapy have shown the ability to reduce toxicity by limiting radiation to the surrounding tissue.
In this video, Steven H. Lin, MD, PhD, of the University of Texas MD Anderson Cancer Center, reviews IMRT and proton therapy, discussing some of the advantages and disadvantages.